Carfilzomib for relapsed and refractory multiple myeloma
K Groen, NWCJ van de Donk, CAM Stege, S Zweegman, IS Nijhof Department of Hematology, VU University Medical Center, Amsterdam, Netherlands Abstract: Although the prognosis of multiple myeloma (MM) patients has dramatically improved during recent years, virtually all patients eventually develop relap...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2019-04-01
|
| Sarja: | Cancer Management and Research |
| Aiheet: | |
| Linkit: | https://www.dovepress.com/carfilzomib-for-relapsed-and-refractory-multiple-myeloma-peer-reviewed-article-CMAR |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|